Rebekah H Gensure1, Michael F Chiang2, John P Campbell2. 1. Department of Ophthalmology & Visual Sciences, John A. Moran Eye Center, University of Utah, Salt Lake City, Utah. 2. Department of Ophthalmology, Oregon Health & Science University, Portland, Oregon, USA.
Abstract
PURPOSE OF REVIEW: In this article, we review the current state of artificial intelligence applications in retinopathy of prematurity (ROP) and provide insight on challenges as well as strategies for bringing these algorithms to the bedside. RECENT FINDINGS: In the past few years, there has been a dramatic shift from machine learning approaches based on feature extraction to 'deep' convolutional neural networks for artificial intelligence applications. Several artificial intelligence for ROP approaches have demonstrated adequate proof-of-concept performance in research studies. The next steps are to determine whether these algorithms are robust to variable clinical and technical parameters in practice. Integration of artificial intelligence into ROP screening and treatment is limited by generalizability of the algorithms to maintain performance on unseen data and integration of artificial intelligence technology into new or existing clinical workflows. SUMMARY: Real-world implementation of artificial intelligence for ROP diagnosis will require massive efforts targeted at developing standards for data acquisition, true external validation, and demonstration of feasibility. We must now focus on ethical, technical, clinical, regulatory, and financial considerations to bring this technology to the infant bedside to realize the promise offered by this technology to reduce preventable blindness from ROP.
PURPOSE OF REVIEW: In this article, we review the current state of artificial intelligence applications in retinopathy of prematurity (ROP) and provide insight on challenges as well as strategies for bringing these algorithms to the bedside. RECENT FINDINGS: In the past few years, there has been a dramatic shift from machine learning approaches based on feature extraction to 'deep' convolutional neural networks for artificial intelligence applications. Several artificial intelligence for ROP approaches have demonstrated adequate proof-of-concept performance in research studies. The next steps are to determine whether these algorithms are robust to variable clinical and technical parameters in practice. Integration of artificial intelligence into ROP screening and treatment is limited by generalizability of the algorithms to maintain performance on unseen data and integration of artificial intelligence technology into new or existing clinical workflows. SUMMARY: Real-world implementation of artificial intelligence for ROP diagnosis will require massive efforts targeted at developing standards for data acquisition, true external validation, and demonstration of feasibility. We must now focus on ethical, technical, clinical, regulatory, and financial considerations to bring this technology to the infant bedside to realize the promise offered by this technology to reduce preventable blindness from ROP.
Authors: James M Brown; J Peter Campbell; Andrew Beers; Ken Chang; Susan Ostmo; R V Paul Chan; Jennifer Dy; Deniz Erdogmus; Stratis Ioannidis; Jayashree Kalpathy-Cramer; Michael F Chiang Journal: JAMA Ophthalmol Date: 2018-07-01 Impact factor: 7.389
Authors: Kishan Gupta; J Peter Campbell; Stanford Taylor; James M Brown; Susan Ostmo; R V Paul Chan; Jennifer Dy; Deniz Erdogmus; Stratis Ioannidis; Jayashree Kalpathy-Cramer; Sang J Kim; Michael F Chiang Journal: JAMA Ophthalmol Date: 2019-07-03 Impact factor: 7.389
Authors: Brittni A Scruggs; R V Paul Chan; Jayashree Kalpathy-Cramer; Michael F Chiang; J Peter Campbell Journal: Transl Vis Sci Technol Date: 2020-02-10 Impact factor: 3.283
Authors: Michael D Abràmoff; Brad Cunningham; Bakul Patel; Malvina B Eydelman; Theodore Leng; Taiji Sakamoto; Barbara Blodi; S Marlene Grenon; Risa M Wolf; Arjun K Manrai; Justin M Ko; Michael F Chiang; Danton Char Journal: Ophthalmology Date: 2021-08-31 Impact factor: 14.277
Authors: Lei Shao; Xiaomei Zhang; Teng Hu; Yang Chen; Chuan Zhang; Li Dong; Saiguang Ling; Zhou Dong; Wen Da Zhou; Rui Heng Zhang; Lei Qin; Wen Bin Wei Journal: Front Med (Lausanne) Date: 2022-03-10
Authors: Jung Ho Han; So Jin Yoon; Hye Sun Lee; Goeun Park; Joohee Lim; Jeong Eun Shin; Ho Seon Eun; Min Soo Park; Soon Min Lee Journal: Yonsei Med J Date: 2022-07 Impact factor: 3.052
Authors: Aaron S Coyner; Jimmy S Chen; Ken Chang; Praveer Singh; Susan Ostmo; R V Paul Chan; Michael F Chiang; Jayashree Kalpathy-Cramer; J Peter Campbell Journal: Ophthalmol Sci Date: 2022-02-11